Heart Disease Clinical Trials in Massachusetts

Showing 121-140 of 451 trials

Thromboxane Receptor Antagonist to Improve Endothelial Function

NCT03962855

This study evaluates whether addition of the thromboxane receptor antagonist to chronic aspirin therapy improves endothelial function and reduces non-platelet thromboxane generation in patients with established cardiovascular disease. Half of participants will receive ifetroban and the other half will receive matching placebo for the 4 week study period.

Cardiovascular DiseasesVascular Dilation

Jeffrey Rade57 participantsStarted Sep 2019

Worcester, Massachusetts, United States

Active Not RecruitingNA26 miles

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

NCT04089059

This is a prospective, open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart Failure Patients compared to a Performance Goal (PG).

Heart Failure NYHA Class III

Endotronix, Inc.738 participantsStarted Jan 2020

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Phoenix, Arizona, United States +71 more locations

Thromboxane Receptor Antagonist to Improve Endothelial Function

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

Heart Disease Trials in Other Cities

FUnctional diagnoSIs of corONary Stenosis (FUSION)

MBCT Via Group Videoconferencing for Acute Coronary Syndrome Patients With Depressive Symptoms: A Pilot RCT

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Benefits of µCor in Ambulatory Decompensated Heart Failure

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Remote-delivered MBCT for SCAD Survivors

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction

Acorai Machine Learning Generalization (MLG) Study

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Alleviate-HF-2 Study

Effect of Fetal Aortic Valvuloplasty on Outcomes

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function

Other Conditions in Massachusetts